Pressmeddelande

Publication of Biohit Oyj Renumeration Report 2022

Cision Publicerad: 22 Mar 2023 08:30

Biohit Oyj Renumeration Report March 22, 2023 at 9:30 am local time (EET)

Biohit Oyj’s Remuneration Report for the Governing Bodies is published today in PDF format. The Remuneration Report for the Governing Bodies is attached to this stock exchange release and also available at https://www.biohithealthcare.com/en/investors/.

Additional information:

CEO Jussi Hahtela, Biohit Oyj
tel. +358 9 773 861
[email protected]
www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com

Bifogade filer

Publication of Biohit Oyj Renumeration Report 2022https://mb.cision.com/Main/18502/3738230/1932313.pdf

Biohit Oyj Remuneration Reporthttps://mb.cision.com/Public/18502/3738230/aebdef13cf278668.pdf

Nyheter om Biohit

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!